In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.
Heart Failure: new targets for treatment
Session

Event : ESC Congress 2018

Topic : Basic Science - Cardiac Biology and Physiology

  • Session type : Abstract Session
  • Date : 27 August 2018
  • Time : 08:30 - 10:00

6 presentations in this session

Positive cardiac inotropy by carvedilol via unique beta-arrestin2-dependent SERCA2a stimulation

Event : ESC Congress 2018

  • Session : Heart Failure: new targets for treatment
  • Speaker : A Lymperopoulos (Fort Lauderdale,US)

HECTD3 attenuates cardiac hypertrophy acting as an E3 ligase of SUMO2

Event : ESC Congress 2018

  • Session : Heart Failure: new targets for treatment
  • Speaker : A Rangrez (Kiel,DE)

RNA methylation in cardiac hypertrophy and heart failure

Event : ESC Congress 2018

  • Session : Heart Failure: new targets for treatment
  • Speaker : E Buchholz (Goettingen,DE)

Get your access to resources

Join now
  • 1ESC Professional Members – access all ESC Congress resources 
  • 2ESC Association Members (Ivory, Silver, Gold) – access your Association’s resources
  • 3Under 40 or in training - with a Combined Membership, access all resources
Join now
logo esc

Our mission: To reduce the burden of cardiovascular disease

Who we are